You can buy or sell Regeneron and other stocks, options, ETFs, and crypto commission-free!
Regeneron Pharmaceuticals, Inc. Common Stock, also called Regeneron, is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Read More It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Tarrytown, New York
52 Week High
52 Week Low
Edited Transcript of REGN earnings conference call or presentation 5-Nov-19 1:30pm GMTQ3 2019 Regeneron Pharmaceuticals Inc Earnings Call TARRYTOWN Dec 13, 2019 (Thomson StreetEvents) -- Edited Transcript of Regeneron Pharmaceuticals Inc earning
Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug CollaborationsRegeneron Pharmaceuticals Inc (NASDAQ: REGN) shares were rebounding Tuesday as investors digested French pharma giant and collaboration partner Sanofi SA's (NAS
Expected Feb 6, Pre-Market